Machine Learning Models Show Promise in Predicting Rectal Cancer Treatment Response

Strategic Insights -

Researchers at Adana Alparslan Turkes Science and Technology University have made a significant breakthrough in using machine learning models to predict the response of rectal cancer patients to neoadjuvant chemoradiotherapy (nCRT). The study, published in Medicine, aimed to compare the performance of various machine learning models in predicting the response to nCRT in rectal cancer patients based on medical data, including radiomic features extracted from computed tomography (CT) scans. The results showed that the gradient boosting classifier and the extra trees classifier (ETC) models demonstrated strong performance in predicting nCRT response, with the ETC model consistently showing the best results in external validation.

Key Takeaways:

  • The study aimed to improve treatment decision-making for rectal cancer patients by developing a noninvasive approach using radiomics and machine learning.
  • The researchers used 101 radiomic features extracted from CT scans and clinical data, including age, gender, tumor grade, and biomarkers.
  • The gradient boosting classifier showed the best training performance with an accuracy of 0.92 and AUC of 0.95, while the ETC model achieved an accuracy of 0.84 and AUC of 0.90 in internal testing.
  • The ETC model consistently showed strong performance in predicting nCRT response in external validation, with an accuracy of 0.75 and AUC of 0.79.
  • The study concluded that patient-specific biomarkers were more influential than radiomic features in the ETC model.
  • The researchers suggested that the model's external validation performance suggests potential for generalization.

Statistics:

  • 112 patients were used in the training set for the machine learning models.
  • 35 patients were used in the internal test set for the ETC model.
  • 40 patients were used in the external test set for the ETC model.
  • The ETC model achieved an accuracy of 0.92, AUC of 0.95, recall of 0.96, precision of 0.93, and F1-score of 0.94 in training.
  • The ETC model achieved an accuracy of 0.84, AUC of 0.90, recall of 0.92, precision of 0.87, and F1-score of 0.90 in internal testing.

Sources:

  • Adana Alparslan Turkes Science and Technology University
  • Medicine (Elsevier) - www.journals.elsevier.com/medicine/
  • Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA.